FIRST WAVE BIOPHARMA (FWBI) Stock Price, Quote, News and Overview

What is the stock price of FIRST WAVE BIOPHARMA today?

The current stock price of FWBI is 2.96 USD. The price increased by 4.59% in the last trading session.

What is the ticker symbol for FIRST WAVE BIOPHARMA stock?

The exchange symbol of FIRST WAVE BIOPHARMA is FWBI and it is listed on the Nasdaq exchange.

On which exchange is FWBI stock listed?

FWBI stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for FIRST WAVE BIOPHARMA stock?

8 analysts have analysed FWBI and the average price target is 36.72 USD. This implies a price increase of 1140.54% is expected in the next year compared to the current price of 2.96. Check the FIRST WAVE BIOPHARMA stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is FIRST WAVE BIOPHARMA worth?

FIRST WAVE BIOPHARMA (FWBI) has a market capitalization of 4.62M USD. This makes FWBI a Nano Cap stock.

How many employees does FIRST WAVE BIOPHARMA have?

FIRST WAVE BIOPHARMA (FWBI) currently has 10 employees.

What are the support and resistance levels for FIRST WAVE BIOPHARMA (FWBI) stock?

FIRST WAVE BIOPHARMA (FWBI) has a support level at 2.6 and a resistance level at 2.96. Check the full technical report for a detailed analysis of FWBI support and resistance levels.

Should I buy FIRST WAVE BIOPHARMA (FWBI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of FWBI, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of FWBI, evaluating the profitability, health, valuation and growth aspects
• FIRST WAVE BIOPHARMA (FWBI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• FIRST WAVE BIOPHARMA (FWBI) Sales and EPS estimates to see what analysts future expectations are.
• FIRST WAVE BIOPHARMA (FWBI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• FIRST WAVE BIOPHARMA (FWBI) Insider and Institutional Ownership to learn about the owners and their transactions.
• FIRST WAVE BIOPHARMA (FWBI) Stock Chart to make your own analysis
• FIRST WAVE BIOPHARMA (FWBI) Latest news and press-releases to stay up to date.

Does FIRST WAVE BIOPHARMA (FWBI) stock pay dividends?

FWBI does not pay a dividend.

When does FIRST WAVE BIOPHARMA (FWBI) report earnings?

FIRST WAVE BIOPHARMA (FWBI) will report earnings on 2024-08-14, before the market open.

What is the Price/Earnings (PE) ratio of FIRST WAVE BIOPHARMA (FWBI)?

FIRST WAVE BIOPHARMA (FWBI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-88.75).

ChartMill assigns a fundamental rating of 1 / 10 to FWBI. FWBI has a bad profitability rating. Also its financial health evaluation is rather negative.

Over the last trailing twelve months FWBI reported a non-GAAP Earnings per Share(EPS) of -88.75. The EPS increased by 75.5% compared to the year before.

ChartMill assigns a Buy % Consensus number of 80% to FWBI. The Buy consensus is the average rating of analysts ratings from 8 analysts.